Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III randomized double-blind study of A-04-01D H5N1 influenza vaccine in healthy Japanese adults
jRCT2080221139Phase 3
- Sponsor
- Denka
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of A-04-01D in influenza, sponsored by Denka. Primary endpoints: Safety of A-04-01D and Immunogenicity of A-04-01D.
02
Drugs
A-04-01D
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080221139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221139.